SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-084288
Filing Date
2019-03-25
Accepted
2019-03-25 07:16:03
Documents
3
Period of Report
2019-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d727340d8k.htm 8-K 19521
2 EX-99.1 d727340dex991.htm EX-99.1 55083
3 GRAPHIC g727340g42b86.jpg GRAPHIC 9732
  Complete submission text file 0001193125-19-084288.txt   89414
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 19701318
SIC: 2834 Pharmaceutical Preparations